Bacitracin Topical Ointment

[16 July 2014]

Products Affected - Description

Bacitracin 500 unit/gram Ointment, Perrigo
0.9 gram, unit-dose, 144 count (NDC 45802-0060-70)
15 gram tube (NDC 45802-0060-01)

Bacitracin 500 unit/gram Ointment, Qualitest
30 gram tube (NDC 00603-0441-50)

Bacitracin 500 unit/gram Ointment, Sandoz
0.9 gram foil packets, unit-dose, 144 count (NDC 00168-0111-09)
15 gram tube (NDC 00168-0011-35)
30 gram tube (NDC 00168-0011-31)
120 gram tube (NDC 00168-0011-04)
454 gram jar (NDC 00168-0011-16)

Reason for the Shortage

Sandoz, Perrigo, and G&W Labs cannot provide a reason for the shortage.

Available Products

Bacitracin 500 unit/gram Ointment, Altaire
30 gram tube (NDC 41280-0200-78)

Bacitracin 500 unit/gram Ointment, G&W Labs
30 gram tube (NDC 00713-0280-31)

Bacitracin 500 unit/gram Ointment, Perrigo
30 gram tube (NDC 45802-0060-03)

Bacitracin 500 unit/gram Ointment, Taro
15 gram tube (NDC 51672-2075-01)
30 gram tube (NDC 51672-2075-02)

Estimated Resupply Dates

  • Perrigo has bacitracin 0.9 gram unit-dose packets on back order and the company estimates a release date of late-July or early-August 2014. The 15 gram tubes are on back order and the company estimates a release date of mid- to late-July 2014.
  • Qualitest has bacitracin 30 gram tubes on back order and the company cannot estimate a release date.
  • Sandoz has bacitracin unit-dose packets, 15 gram tubes, and 30 gram tubes on back order and the company estimates a release date in early-August 2014. Bacitracin 120 gram tubes and 454 gram jars are on back order and the company estimates a release date in mid-October 2014.

Related Shortages


July 16, 2014; June 5, 2014, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.


This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.